The Plenary of the Chamber of Commerce of Spain has made official the appointment of Marc Soriano, current Executive Director of Portfolio and External Relations for R&D at almirallas the new president of the Research and Innovation Commission. This appointment has the strategic objective of strengthening the Spanish R&D&I ecosystem and improving the competitiveness of the national business sector.
Marc Soriano, who replaces in the position Pere BergaHe brings a solid academic and corporate background. He holds a PhD in Neurobiology from the University of BarcelonaSoriano has accumulated more than a decade of experience in biomedical research, combining academic rigor with the vision of the international pharmaceutical industry.
Linked to almirall Since 2001, she has led key projects in R&D, alliance management, and strategic planning. She is currently part of the company's research and development management team, where she has driven disruptive initiatives such as the launch of The Hive (Almirall Innovation Hub), a platform designed to connect startups and biotechnology companies with the scientific community to accelerate new treatments.
“Assuming the presidency of this Commission is a great responsibility and an opportunity to contribute to strengthening research and innovation in our country. It is also an honor that allows me to continue the commitment of almirall "with R&D&I," the new president declared.
Roadmap: European regulations and SME competitiveness
Under the new presidency, the Research and Innovation Commission has established a clear roadmap to strengthen Spain's R&D&I framework. Efforts will focus on creating a favorable environment for investment and improving access to finance, critical factors for the internationalization and growth of Spanish companies, with a particular focus on small and medium-sized enterprises (SMEs).
The following details the key information regarding the appointment and the strategic priorities for this new phase:
| Data / Area | Detail |
|---|---|
| New President | Marc Soriano (Almirall) |
| Previous Position | Pere Berga |
| Training | PhD in Neurobiology (University of Barcelona) |
| EU Regulatory Focus | European Innovation Act, Regime 28, Biotech Act |
| Study Models | International Innovation (The Case of China) |
In addition to funding, the Commission will closely monitor EU regulations that directly affect trade and industry. Priority regulations include:
- La European Innovation Act.
- El Regime 28.
- El Biotech Act.
International models of successful innovation will also be analyzed, paying special attention to the case of Chinato draw lessons applicable to the Spanish context. Finally, cross-cutting collaboration with other committees of the Chamber of Spain to address challenges such as attracting and retaining talent and the effective transfer of technological knowledge.
Key points and frequently asked questions about the Innovation Commission
Who is Marc Soriano and what does he contribute to the Spanish Chamber of Commerce?
He is the Executive Director of Portfolio and External Relations for R&D at almirall and holds a PhD in Neurobiology. He brings more than 10 years of experience in biomedical research and strategic management of pharmaceutical innovation.
What are the main objectives of your term?
Strengthening the R&D&I framework in Spain, improving financing and the investment environment, and boosting the competitiveness of national companies, especially SMEs.
Which international regulations will the Commission monitor?
The Commission will focus its analysis on key European regulations such as European Innovation Act and the Biotech Actas well as studying innovation models from global markets such as China.
Any questions about this news?
Talk to Coexia, the AI of the foreign trade
International business service providers
Credit and caution
Leading operator of domestic and export credit insurance in Spain, with a market share of 46%.read more...
Cesce
Cesce, the Spanish Export Credit Insurance Company, is the head of a group.read more...
